University of Maryland, Baltimore (UMB) President Bruce E. Jarrell, MD, FACSannounced on January 24 that Natalie D. Eddington, PhD, FAAPS, FCP, has decided to step down as dean of the University of Maryland School of Pharmacy (UMSOP) at the end of this academic year. She will remain on the faculty and will lead UMB’s EMBRACE initiative, a multifaceted approach designed to increase the vibrancy of the greater UMB campus, increase UMB’s community impact in West Baltimore, and strengthen UMB’s profile with our internal and external constituencies.
“Dean Eddington’s long and impactful tenure at UMB has been characterized by building and leading strong teams, strategic and entrepreneurial thinking, competent and results-oriented management and establishing and maintaining strong and meaningful relationships. As a result of her leadership, the School of Pharmacy is positioned for continued success,” Jarrell said in his announcement. “These qualities will be essential in shaping the important new UMB EMBRACE initiative that she will lead.”
An alumna of the school, Eddington has served as dean since 2007, after serving UMSOP as assistant professor, chair of the Department of Pharmaceutical Sciences and director of the Pharmacokinetics-Biopharmaceutics Laboratory.
A nationally recognized expert in drug delivery and pharmacokinetics, Eddington focuses his research on drugs used to treat cancer, epilepsy, arthritis, and substance abuse, and on understanding the role of biopharmaceutics and pharmacokinetics in elucidating the underlying mechanisms that are important for the optimization of medicines. therapy. Her research has served as the basis for several regulatory guidances implemented by the Food and Drug Administration (FDA).
Under her leadership, UMSOP has established several centers and programs, including Center for Innovative Pharmacy Solutions; that Patients, pharmacists, partnership program; The PATIENTS program; that Bio- and Nanotechnology Center; that Center for Translational Medicine; that Mass Spectrometry Center; that Metallotherapeutic Research Centreand Maryland Center of Excellence in Regulatory Science and Innovation. In addition, Eddington has designed several international regulatory courses for clinicians and scientists from South Korea, Argentina, Brazil, the United States and Japan on the US drug development process and the FDA’s regulatory infrastructure around drug and device development. Most recently, under her leadership, UMSOP launched a transformation Pharmapreneurship initiative.
During his tenure, Eddington oversaw the expansion of the School of Pharmacy’s physical footprint with the opening of the Pharmacy Hall Addition in 2010, a 126,000-square-foot, seven-story building that provided modern learning, work, research and collaboration spaces for faculty, staff and students. She also oversaw the expansion of the school’s academic offerings, which now include Doctor in pharmacy program, three PhD programmesand six MS programsincluding the first of its kind MS in Medical Cannabis Science and Therapy.
“The majority of my professional life has been spent at the University of Maryland School of Pharmacy, an institution that I love,” Eddington said. “It is here that I have learned, grown and served an exceptional community of students, faculty, staff, faculty, alumni and collaborators. It has been the honor of my career to serve as dean for the past 15 years and to have had a seat at the forefront range to witness the expertise, influence and impact of our researchers, practitioners, researchers and professionals.”
A national search for a new UMSOP dean will be conducted.